CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
Nobutaka Hanagata1,2 1Nanotechnology Innovation Station, National Institute for Materials Science, Tsukuba, Ibaraki, 2Graduate School of Life Science, Hokkaido University, Sapporo, Hokkaido, Japan Abstract: Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG ODNs), which...
Guardado en:
Autor principal: | Hanagata N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91c8a9dd1b704c99a1bb001f036d8585 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFRL858R/T790M mutation
por: Wang G, et al.
Publicado: (2019) -
INFLUENCE OF CpG ODN 2006 OLIGODEOXYNUCLEOTIDE ON CYTOKINE PRODUCTION BY BLOOD CELLS OF HUMANS VACCINATED AGAINST PLAGUE
por: S. N. Klyueva, et al.
Publicado: (2015) -
Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities
por: Hanagata N, et al.
Publicado: (2017) -
Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice
por: Li,Xuan, et al.
Publicado: (2016) -
STRUCTURE AND IMMUNE ADJUVANT PROPERTIES OF CPG-D
por: V. S. Polovinkina, et al.
Publicado: (2014)